SEC Filing Summary: Hexindai Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by Hexindai Inc. for the month of June 2019. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Qisen (Johnson), Chief Financial Officer, on June 4, 2019. The filing includes a press release as Exhibit 99.1.
Financial Metrics
The provided filing text contains only the cover page and exhibit index. It does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for any financial metric.
Material Changes
No material changes versus the prior comparable period are described in the provided text, as the document lacks financial data or comparative analysis.
Guidance, Outlook, and Risks
The provided text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are likely contained within the referenced Exhibit 99.1 (Press Release), which is not included in the input content.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Press Release) for the actual announcement details.
- Confirm the discrepancy between the requested company name "Akso Health Group" and the registrant name "Hexindai Inc." listed on the filing.
- Note that the filing date (June 4, 2019) precedes the period end date mentioned in the metadata (June 30, 2019).
- Review the full press release for any material events or financial updates not captured in the cover page.